MEDI-8662 and CAIV-T flu vaccines demonstrate comparable safety/immunogenicity in phase III trial Nov. 9, 2010
Several phase II/III trials show safety and efficacy of fingolimod in relapsing-remitting MS Nov. 9, 2010
Intranasal GI.1 norovirus virus-like particle vaccine is safe and efficacious in healthy volunteers Nov. 8, 2010
RSS